NN414

Danish Headache Center · Phase 1 active Small molecule

At a glance

Generic name	NN414
Also known as	6-Chloro-3-[[1-methylcyclopropyl]amino]-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide
Sponsor	Danish Headache Center
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Headache Inducing Effect of NN414 in Migraine Patients (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

NN414 CI brief — competitive landscape report
NN414 updates RSS · CI watch RSS
Danish Headache Center portfolio CI